TY  - GEN
AU  - Guo,Shan-Shan
AU  - Tang,Lin-Quan
AU  - Zhang,Lu
AU  - Chen,Qiu-Yan
AU  - Liu,Li-Ting
AU  - Guo,Ling
AU  - Mo,Hao-Yuan
AU  - Luo,Dong-Hua
AU  - Huang,Pei-Yu
AU  - Xiang,Yan-Qun
AU  - Sun,Rui
AU  - Chen,Ming-Yuan
AU  - Wang,Lin
AU  - Lv,Xing
AU  - Zhao,Chong
AU  - Guo,Xiang
AU  - Cao,Ka-Jia
AU  - Qian,Chao-Nan
AU  - Zeng,Mu-Sheng
AU  - Bei,Jin-Xin
AU  - Hong,Ming-Huang
AU  - Shao,Jian-Yong
AU  - Sun,Ying
AU  - Ma,Jun
AU  - Mai,Hai-Qiang
TI  - The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy
SN  - 1471-2407
PY  - 2016///0831
KW  - Adult
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Carcinoma
KW  - Chemoradiotherapy
KW  - methods
KW  - Cisplatin
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Nasopharyngeal Carcinoma
KW  - Nasopharyngeal Neoplasms
KW  - drug therapy
KW  - Proportional Hazards Models
KW  - Radiotherapy, Intensity-Modulated
KW  - Retrospective Studies
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/s12885-015-1964-8
ER  -